[Determining resistance in HIV therapy. Careful interpretation only].
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002219:Carbamates; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects; D004352:Drug Resistance, Microbial; D005663:Furans; D006678:HIV / Q000187:drug effects* / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D009154:Mutation / Q000235:genetics; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D000099227:Abacavir
D019380:Anti-HIV Agents; D002219:Carbamates; D015224:Dideoxynucleosides; D005663:Furans; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir